Additionally, Gene Set Enrichment Analysis (GSEA) and enzyme-linked immunosorbent assay (ELISA) were performed to evaluate the expression of CXCR2 in prostate cancer (PCA). This evidence concerns the gene CXCR2 and prostate carcinoma.